These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22946947)

  • 21. Regional consistency and sample size considerations in a multiregional equivalence trial.
    Wu SC; Xu JF; Zhang XJ; Li ZW; He J
    Pharm Stat; 2020 Nov; 19(6):897-908. PubMed ID: 32716135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploratory analyses of efficacy data from schizophrenia trials in support of new drug applications submitted to the US Food and Drug Administration.
    Khin NA; Chen YF; Yang Y; Yang P; Laughren TP
    J Clin Psychiatry; 2012 Jun; 73(6):856-64. PubMed ID: 22687813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unified additional requirement in consideration of regional approval for multiregional clinical trials.
    Teng Z; Chen YF; Chang M
    J Biopharm Stat; 2017; 27(6):903-917. PubMed ID: 28287339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A predictive Bayesian approach to the design and analysis of bridging studies.
    Gould AL; Jin T; Zhang LX; Wang WW
    J Biopharm Stat; 2012 Sep; 22(5):916-34. PubMed ID: 22946940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Quantitative Method for Weight Selection in SGDDP.
    Huang Q; Chen G; Yuan Z; Zhang Y; Wenrich J
    J Biopharm Stat; 2015; 25(6):1179-89. PubMed ID: 25365548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ethnic sensitive or molecular sensitive beyond all regions being equal in multiregional clinical trials.
    Wang SJ; James Hung HM
    J Biopharm Stat; 2012 Sep; 22(5):879-93. PubMed ID: 22946937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An empirical Bayes approach to evaluation of results for a specific region in multiregional clinical trials.
    Huang Y; Chang WJ; Hsiao CF
    Pharm Stat; 2013; 12(2):59-64. PubMed ID: 23319408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of prior information for Bayesian evaluation of bridging studies.
    Hsiao CF; Hsu YY; Tsou HH; Liu JP
    J Biopharm Stat; 2007; 17(1):109-21. PubMed ID: 17219758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sample size considerations for Japanese patients in a multi-regional trial based on MHLW guidance.
    Quan H; Zhao PL; Zhang J; Roessner M; Aizawa K
    Pharm Stat; 2010; 9(2):100-12. PubMed ID: 19499510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Empirical shrinkage estimator for consistency assessment of treatment effects in multi-regional clinical trials.
    Quan H; Li M; Shih WJ; Ouyang SP; Chen J; Zhang J; Zhao PL
    Stat Med; 2013 May; 32(10):1691-706. PubMed ID: 22855311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A nested group sequential framework for regional evaluation in global drug development program.
    Wang W; Jiang Z; Qiu J; Xia J; Guo X
    J Biopharm Stat; 2017; 27(6):945-962. PubMed ID: 28323515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing the consistency of the treatment effect under the discrete random effects model in multiregional clinical trials.
    Liu JT; Tsou HH; Gordon Lan KK; Chen CT; Lai YH; Chang WJ; Tzeng CS; Hsiao CF
    Stat Med; 2016 Jun; 35(14):2301-14. PubMed ID: 26833851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cautionary note on regional consistency evaluation in multiregional clinical trials with binary outcomes.
    Homma G
    Pharm Stat; 2024; 23(3):385-398. PubMed ID: 38124266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of homogeneity of treatment effect in adaptive multicenter clinical trials.
    Chen L; Tamura RN
    J Biopharm Stat; 1998 Mar; 8(1):55-67. PubMed ID: 9547427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An adaptive strategy for assessing regional consistency in multiregional clinical trials.
    Chen J; Quan H; Gallo P; Ouyang SP; Binkowitz B
    Clin Trials; 2012 Jun; 9(3):330-9. PubMed ID: 22436444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sample size allocation in multiregional equivalence studies.
    Liao JJZ; Yu Z; Li Y
    Pharm Stat; 2018 Sep; 17(5):570-577. PubMed ID: 29911346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Graphical assessment of consistency in treatment effect among countries in multi-regional clinical trials.
    Chen J; Zheng H; Quan H; Li G; Gallo P; Ouyang SP; Binkowitz B; Ting N; Tanaka Y; Luo X; Ibia E;
    Clin Trials; 2013; 10(6):842-51. PubMed ID: 24013404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bridging bioequivalence studies.
    Liu JP
    J Biopharm Stat; 2004 Nov; 14(4):857-67. PubMed ID: 15587968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Bayesian approach for inference from a bridging study with binary outcomes.
    Gandhi M; Mukherjee B; Biswas D
    J Biopharm Stat; 2012 Sep; 22(5):935-51. PubMed ID: 22946941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blinded sample size recalculation in multicentre trials with normally distributed outcome.
    Jensen K; Kieser M
    Biom J; 2010 Jun; 52(3):377-99. PubMed ID: 20394080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.